ENDONUCLEASE V EXPRESSION IN HUMAN CELLS
人类细胞中核酸内切酶 V 的表达
基本信息
- 批准号:3193803
- 负责人:
- 金额:$ 12.7万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1989
- 资助国家:美国
- 起止时间:1989-12-01 至 1992-11-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The eukaryotic DNA repair pathway involved in the repair of UV-induced
lesions is thought to be at least as complex as the E. coli UvrA,B,C system.
This complexity is inferred in the identification of ten different xeroderma
pigmentosum (XP) complementation groups deficient in incision at UV-induced
lesions. In contrast, endonuclease V encoded by the denV gene of
bacteriophage T4, a pyrimidine dimer-DNA glycosylase with associated
apyrimidinic endonuclease activity, has the capacity to initiate DNA repair
as a single enzyme by incising specifically at pyrimidine dimers. The denV
gene has been identified, sequenced and cloned in Escherichia coli,
facilitating construction of denV plasmid vectors suitable for introduction
into eukaryotic cells, including XP cells. XP cells have been instrumental
in elucidating the effects of UV-induced photoproducts on biological
processes due to their inability to repair them. During our study of denV-
encoded endonuclease V-catalyzed UV repair in eukaryotic cells, three novel
and interesting experimental observations have been made: (i) although UV
excision repair and reporter gene expression can be restored to near normal
levels by denV-encoded endonuclease V, cell survival is not restored to wild
type; (ii) in contrast to the endogenous repair, which can be nonrandom and
restricted to active genes, endonuclease V-catalyzed repair occurs
throughout the entire genome; and (iii) the nucleotide patch size removed
during endonuclease V-catalyzed pyrimidine dimer repair is much smaller than
that in UV-irradiated normal cells. Primarily, two photoproducts, the
abundant pyrimidine dimer and less abundant (6-4)TC pyrimidine-pyrimidone
photoproducts [6-4]photoproducts), have been implicated in the diverse
biological effects of UV light. Because neither pyrimidine dimers nor (6-
4)photoproducts are removed by XP cells, it has not been possible to
unequivocally distinguish their individual contributions to the biological
consequences of UV damage in vivo. Recently an XP revertant cell line has
been described which repairs (6-4)TC photoproducts but not the pyrimidine
dimers. Introducing the denV gene into XP and revertant XP cells provides
an opportunity to separately analyze the effects of pyrimidine dimers and
(6-4)TC photoproducts on DNA synthesis, transcription, survival, repair and
mutations in human cells; and affords as the opportunity to examine the
function of a well characterized DNA repair enzyme in normal and repair-
deficient human cells.
紫外线诱导的维修的真核DNA修复途径
病变被认为至少与大肠杆菌UVRA,B,C系统一样复杂。
在识别十个不同的xeroderma时,可以推断出这种复杂性
色素(XP)互补组缺乏紫外线诱导的切口
病变。 相比之下,核酸内切酶V v由DENV基因编码
噬菌体T4,一种与相关的嘧啶二聚体-DNA糖基酶
丙酰胺核酸内切酶活性具有启动DNA修复的能力
作为单个酶,通过在嘧啶二聚体上特异性切割。 DENV
基因已在大肠杆菌中鉴定,测序和克隆,
促进适合引入的DENV质粒载体的构造
进入包括XP细胞在内的真核细胞。 XP细胞已经有用
阐明紫外线诱导的光产物对生物学的影响
过程由于无法修复它们。 在我们研究denv-
真核细胞中编码的内切酶V催化的紫外线修复,三个新型
并进行了有趣的实验观察:(i)尽管紫外线
切除修复和报告基因表达可以恢复到接近正常
DENV编码的核酸内切酶V的水平,细胞存活未恢复为野生
类型; (ii)与内源性修复相反,这可以是非随机的
核酸内切酶V催化修复限制为活性基因
在整个基因组中; (iii)除去核苷酸斑块大小
在核酸内切酶中V催化的嘧啶二聚体修复远小于
在紫外线辐射的正常细胞中。 主要是两个光产物,
丰富的嘧啶二聚体和较少丰富的(6-4)TC嘧啶 - 吡啶酮
光产物[6-4]光产物)已与多样化有关
紫外光的生物学作用。 因为嘧啶二聚体也没有(6-
4)XP细胞去除光吸收,不可能
明确区分他们对生物学的个人贡献
体内紫外线损伤的后果。 最近,XP恢复细胞系具有
被描述了哪些修复(6-4)TC光产物,而不是嘧啶
二聚体。 将DENV基因引入XP和Reververtant XP细胞提供
有机会分别分析嘧啶二聚体和
(6-4)DNA合成,转录,生存,修复和修复的TC光产物
人类细胞中的突变;并提供了检查的机会
在正常和修复中表征良好的DNA修复酶的功能 -
不足的人类细胞。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
EARL E HENDERSON的其他基金
OPIOIDS EFFECTS ON HIV1 REPLICATION AND REACTIVATION
阿片类药物对 HIV1 复制和重新激活的影响
- 批准号:28982962898296
- 财政年份:1998
- 资助金额:$ 12.7万$ 12.7万
- 项目类别:
OPIOIDS EFFECTS ON HIV1 REPLICATION AND REACTIVATION
阿片类药物对 HIV1 复制和重新激活的影响
- 批准号:61755676175567
- 财政年份:1998
- 资助金额:$ 12.7万$ 12.7万
- 项目类别:
OPIOIDS EFFECTS ON HIV1 REPLICATION AND REACTIVATION
阿片类药物对 HIV1 复制和重新激活的影响
- 批准号:27189452718945
- 财政年份:1998
- 资助金额:$ 12.7万$ 12.7万
- 项目类别:
ETIOLOGY OF AIDS-RELATED EBV-ASSOCIATED T CELL LYMPHOMA
艾滋病相关 EBV 相关 T 细胞淋巴瘤的病因学
- 批准号:26492862649286
- 财政年份:1997
- 资助金额:$ 12.7万$ 12.7万
- 项目类别:
SYNERGY BETWEEN EBV AND HIV 1 DURING LYMPHOGENESIS
EBV 和 HIV 1 在淋巴生成过程中的协同作用
- 批准号:21084022108402
- 财政年份:1994
- 资助金额:$ 12.7万$ 12.7万
- 项目类别:
SYNERGY BETWEEN EBV AND HIV 1 DURING LYMPHOGENESIS
EBV 和 HIV 1 在淋巴生成过程中的协同作用
- 批准号:21084012108401
- 财政年份:1994
- 资助金额:$ 12.7万$ 12.7万
- 项目类别:
SYNERGY BETWEEN EBV AND HIV 1 DURING LYMPHOGENESIS
EBV 和 HIV 1 在淋巴生成过程中的协同作用
- 批准号:21084002108400
- 财政年份:1994
- 资助金额:$ 12.7万$ 12.7万
- 项目类别:
ENDONUCLEASE V EXPRESSION IN HUMAN CELLS
人类细胞中核酸内切酶 V 的表达
- 批准号:31938053193805
- 财政年份:1989
- 资助金额:$ 12.7万$ 12.7万
- 项目类别:
ENDONUCLEASE V EXPRESSION IN HUMAN CELLS
人类细胞中核酸内切酶 V 的表达
- 批准号:31938043193804
- 财政年份:1989
- 资助金额:$ 12.7万$ 12.7万
- 项目类别:
INHIBITION OF HIV REPLICATION BY DHEA AND ITS ANALOGS
DHEA 及其类似物抑制 HIV 复制
- 批准号:31433103143310
- 财政年份:1989
- 资助金额:$ 12.7万$ 12.7万
- 项目类别:
相似国自然基金
Sin3复合体通过液-液相分离调控DNA复制的机制研究
- 批准号:32300562
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
组蛋白变体H2A.Z第98位丝氨酸的磷酸化修饰在DNA复制起始和复制压力调控中的作用机制
- 批准号:32370647
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
DNA复制叉偶联的姐妹染色单体黏连建立机制与构象基础
- 批准号:32300074
- 批准年份:2023
- 资助金额:20 万元
- 项目类别:青年科学基金项目
单纯疱疹病毒DNA复制起始复合物的动力学与结构研究
- 批准号:32371286
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
酿酒酵母DNA复制所需还原物类型及其精准供给机制
- 批准号:32300436
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Interplay between reverse transcription and host restriction
逆转录与宿主限制之间的相互作用
- 批准号:1060708610607086
- 财政年份:2023
- 资助金额:$ 12.7万$ 12.7万
- 项目类别:
Full-length sequencing of individual RNAs from heterogeneous samples
对异质样品中的单个 RNA 进行全长测序
- 批准号:1048232110482321
- 财政年份:2022
- 资助金额:$ 12.7万$ 12.7万
- 项目类别:
HTLV-1 Replication/Reactivation-Induced DNA Damage: Mechanisms and Pathogenesis
HTLV-1 复制/重新激活诱导的 DNA 损伤:机制和发病机制
- 批准号:1057290710572907
- 财政年份:2022
- 资助金额:$ 12.7万$ 12.7万
- 项目类别:
Role of APOBEC3 in in vivo Restriction of Retrovirus Infection
APOBEC3 在体内限制逆转录病毒感染中的作用
- 批准号:1060697010606970
- 财政年份:2010
- 资助金额:$ 12.7万$ 12.7万
- 项目类别: